Functional Dynamics of Cytochrome P4503A4
Functional Dynamics of Cytochrome P4503A4
批准号:
10205098
负责人:
WILLIAM M ATKINS
金额:
$41.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-18 至 2024-06-30
关键词:
Active SitesAffinityAnaerobic BacteriaBehaviorBindingBinding SitesBiochemicalBiochemistryBiophysicsBromocriptineCYP3A4 geneCatalysisCessation of lifeCharacteristicsClinical ResearchCompetenceComplexCrystallizationCytochromesDataDeuteriumDrug DesignDrug InteractionsDrug TargetingEquilibriumExhibitsFaceFluconazoleFrequenciesHemeHepaticHumanHydrogenHydrogen BondingHydrogen PeroxideIn VitroKineticsKnowledgeLigand BindingLigandsLinkLipid BilayersLipidsMapsMass Spectrum AnalysisMeasuresMechanicsMembraneMembrane LipidsMethodsMidazolamModelingMolecularMolecular ConformationMonitorMotionOpticsOxidation-ReductionPathway interactionsPharmaceutical PreparationsPharmacologyPlayProcessProlinePropertyProtein DynamicsProtein IsoformsReactionRecording of previous eventsRegulationResolutionRoleSourceSpecificityStructureToxic effectUncertaintyWaterWorkXenobioticsbasecofactordetoxicationdrug clearancedrug metabolismexperimental studyimprovedinhibitor/antagonistinter-individual variationinterestmolecular dynamicsmolecular mechanicsnanodisknovelpredictive modelingpreventquantumresponseside effecttraittranslational model
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The proposed work aims to clarify longstanding mechanistic uncertainties about drug metabolizing cytochrome
P450s (CYPs). These CYPs are extraordinarily substrate promiscuous and they are major determinants of
xenobiotic detoxication, drug metabolism and drug interactions. Because of their role in drug metabolism, they
are also drug targets, wherein their pharmacological manipulation can afford control of therapy with other drugs.
One focus here is the knowledge gap concerning the relationship between ligand-dependent heme spin state
and catalytic properties. In the CYP canonical catalytic reaction cycle developed for substrate specific
isoforms, the substrate displaces heme bound water and causes a shift from low spin to high spin heme with
concomitant shift in the heme properties that facilitate reduction and progress through the catalytic cycle. In
contrast, with drug metabolizing CYPs, many drugs cause no shift to high spin heme, but they are efficiently
metabolized or cause hydrogen peroxide formation, both of which require progression through the catalytic
cycle. Recent results demonstrate that many of these substrates hydrogen bond to the axial water, rather than
displace it. The catalytic properties of these water-bridged complexes have not been determined. Therefore,
the proposed work will determine for CYP3A4 the heme redox properties and the catalytic competence of
water-bridged complexes, using computational approaches and advanced biochemical methods including
spectropotentiometry and stopped-flow reaction kinetics. Computational approaches will also be employed to
understand the effect of water-bridged complexes on heme reduction processes.
A second focus of the proposed work aims to clarify the role of conformational dynamics in the complex
allosteric behavior of CYPs and their remarkable substrate promiscuity. Both traits are linked to the protein
dynamics, which remain poorly characterized, and unclarified by the available crystal structures. The allosteric
properties confound prediction of drug clearance and drug interactions, so there is great interest in translational
models that better predict drug interactions based on refined allosteric models. Here, the experimental
methods of hydrogen-deuterium exchange mass spectrometry (H/DX) and pre-steady state ligand binding
methods with CYP3A4 in lipid bilayer nanodiscs are combined with computational approaches such as
accelerated Molecular Dynamics simulations (aMD) and steered molecular dynamics. The proposed studies fill
a significant gap in understanding the, previously experimentally inaccessible, CYP dynamics in a lipid
membrane and the role of conformational dynamics in achieving substrate promiscuity and allostery.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.abb.2021.109064
发表时间:
2021-12-15
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Redhair M, Atkins WM]
通讯作者:
Atkins WM
DOI:
10.1016/j.jinorgbio.2018.02.021
发表时间:
2018-06
期刊:
Journal of inorganic biochemistry
影响因子:
3.9
作者:
[Lockart MM, Rodriguez CA, Atkins WM, Bowman MK]
通讯作者:
Bowman MK
Low molecular weight ligands bind to CYP3A4 via a branched induced fit mechanism: Implications for O2 binding.
低分子量配体通过分支诱导拟合机制与 CYP3A4 结合:对 O2 结合的影响。
DOI:
10.1016/j.abb.2023.109582
发表时间:
2023
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Redhair,Michelle, Nath,Abhinav, Hackett,JohnC, Atkins,WilliamM]
通讯作者:
Atkins,WilliamM
Multiple drug binding modes in Mycobacterium tuberculosis CYP51B1.
结核分枝杆菌 CYP51B1 中的多种药物结合模式。
DOI:
10.1016/j.jinorgbio.2020.110994
发表时间:
2020
期刊:
Journal of inorganic biochemistry
影响因子:
3.9
作者:
[Lockart,MollyM, Butler,JosephT, Mize,CarsonJ, Fair,MorganN, Cruce,AlexA, Conner,KipP, Atkins,WilliamM, Bowman,MichaelK]
通讯作者:
Bowman,MichaelK
Drug, Nucleotide, and Lipid Interactions with P-glycoprotein
-
批准号:10672242
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2022
-
负责人:WILLIAM M ATKINS
-
依托单位:
Functional Dynamics of Cytochrome P4503A4
-
批准号:9638812
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2018
-
负责人:WILLIAM M ATKINS
-
依托单位:
P450-Base Drug Interactions with Low Spin Drugs
-
批准号:8716902
-
项目类别:
-
资助金额:$45.19万
-
财政年份:2013
-
负责人:WILLIAM M ATKINS
-
依托单位:
P450-Base Drug Interactions with Low Spin Drugs
-
批准号:9120388
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2013
-
负责人:WILLIAM M ATKINS
-
依托单位:
P450-Base Drug Interactions with Low Spin Drugs
-
批准号:8740514
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2013
-
负责人:WILLIAM M ATKINS
-
依托单位:
Molecular Mechanisms of P-Glycoprotein
-
批准号:8162138
-
项目类别:
-
资助金额:$29.51万
-
财政年份:2011
-
负责人:WILLIAM M ATKINS
-
依托单位:
Molecular Mechanisms of P-Glycoprotein
-
批准号:8336839
-
项目类别:
-
资助金额:$28.11万
-
财政年份:2011
-
负责人:WILLIAM M ATKINS
-
依托单位:
Molecular Mechanisms of P-Glycoprotein
-
批准号:8531994
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2011
-
负责人:WILLIAM M ATKINS
-
依托单位:
P450 Allosterism and Drug Interactions
-
批准号:7559323
-
项目类别:
-
资助金额:$23.71万
-
财政年份:2008
-
负责人:WILLIAM M ATKINS
-
依托单位:
MECHANISMS OF CYTOCHROME P450 ALLOSTERY
-
批准号:6701456
-
项目类别:
-
资助金额:$21.62万
-
财政年份:2003
-
负责人:WILLIAM M ATKINS
-
依托单位:
Conformational Dynamics in Glutathione S-Transferase
-
批准号:6621762
-
项目类别:
-
资助金额:$22.92万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Conformational Dynamics in Glutathione S-Transferase
-
批准号:6436574
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Conformational Dynamics in Glutathione S-Transferase
-
批准号:6840399
-
项目类别:
-
资助金额:$22.9万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutamine Synthetase Inhibitors for Tuberculosis Therapy
-
批准号:6762446
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutamine Synthetase Inhibitors for Tuberculosis Therapy
-
批准号:6606878
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Conformational Dynamics in Glutathione S-Transferase
-
批准号:6687264
-
项目类别:
-
资助金额:$22.91万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutathione S-Transferases and Oxidative Stress
-
批准号:8006392
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutamine Synthetase Inhibitors for Tuberculosis Therapy
-
批准号:6450223
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
Glutathione S-Transferases and Oxidative Stress
-
批准号:7556363
-
项目类别:
-
资助金额:$27.71万
-
财政年份:2002
-
负责人:WILLIAM M ATKINS
-
依托单位:
TIME RESOLVED TRYPTOPHAN FLUORESCENCE FROM CYTOCHROME B5
-
批准号:6444733
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2001
-
负责人:WILLIAM M ATKINS
-
依托单位:
海外基金